These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25636897)

  • 1. The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma – a report of a case.
    Mori Y; Nagasaka T; Mishima H; Umeda Y; Inada R; Kishimoto H; Goel A; Fujiwara T
    BMC Med Genet; 2015 Jan; 16():1. PubMed ID: 25636897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
    Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
    Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
    J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
    Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
    Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.
    Sviatoha V; Tani E; Ghaderi M; Kleina R; Skoog L
    Anticancer Res; 2010 Sep; 30(9):3267-72. PubMed ID: 20944096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
    Walczyk A; Kowalska A; Kowalik A; Sygut J; Wypiórkiewicz E; Chodurska R; Pięciak L; Góźdź S
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):899-904. PubMed ID: 24354346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA mutations predict local recurrences in rectal cancer patients.
    He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
    Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
    Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
    Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
    Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
    Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast metastasis from rectal cancer with BRAF V600E mutation: a case report with a review of the literature.
    Hasegawa H; Nagata Y; Sakakibara Y; Miyake M; Mori K; Masuda N; Mano M; Nakazuru S; Ishida H; Mita E
    Clin J Gastroenterol; 2020 Apr; 13(2):153-157. PubMed ID: 31482523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAF
    Cho SM; Esmail A; Abdelrahim M
    Front Pharmacol; 2021; 12():795381. PubMed ID: 34975492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report.
    Wang Z; Ye CY; Zhou WL; Wang MM; Dai WP; Zheng J; Zang YS
    Onco Targets Ther; 2020; 13():11849-11853. PubMed ID: 33235471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.
    Moisset L; Raimbourg J; Hiret S; Dauve J; Boisdron-Celle M; Senellart H; Raoul JL
    Case Rep Oncol; 2019; 12(2):426-429. PubMed ID: 31244646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdoid carcinoma of the rectum.
    Samalavicius NE; Stulpinas R; Gasilionis V; Baltruskeviciene E; Aleknavicius E; Mickys U
    Ann Coloproctol; 2013 Dec; 29(6):252-5. PubMed ID: 24466541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-small Cell Lung Cancer With Proto-Oncogene B-Raf V600E Presenting a Distinctive Clinical Course: A Case Report.
    Sasada A; Yuba T; Shiotsu S; Tsuji T; Hiraoka N
    Cureus; 2022 Mar; 14(3):e23055. PubMed ID: 35464513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.
    Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Fu J
    Onco Targets Ther; 2021; 14():989-993. PubMed ID: 33603403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
    Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.